Pharmaceutical firm Gilead has admitted paying hundreds of thousands of dollars in illegal kickbacks to US doctors between ...

Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in ...

Gilead Sciences has agreed to pay $202 million to resolve allegations that it violated the Anti-Kickback Statute by using speaker programs to incentivize physicians to prescribe HIV medications.

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.

Gilead will pay $202 million to resolve claims that it paid kickbacks to healthcare providers in the form of honoraria, meals ...

You could earn truly passive income with these investments. Find out how much you'll make in a single year, depending on how ...

Here are 10 recent healthcare industry lawsuits, settlements and legal developments that Becker's has reported since April 22: ...

Altesa BioSciences, Inc., a clinical-stage pharmaceutical company developing new treatments for viral infections in vulnerable populations, today announced the appointment of Katharine Knobil, M.D. as ...

The U.S. stock market saw gains on Tuesday as investors remained hopeful about a potential trade deal. The White House suggested that a major agreement could be announced soon. The Dow Jones ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

In April, the wild swings in policy positions from the White House resulted in similarly wild swings for the stock market. On one hand, investors hate uncertainty and the continually moving targets ...